48.78

5.17% 2.40

Praxis Precision Medicines Inc (PRAX)

Overview News Price History Option Chain Financials Discussions Forecast

Praxis Precision Medicines Inc stock is traded at $48.78, with a volume of 317.15K. It is up +5.17% in the last 24 hours and down -11.97% over the past month. Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.

Previous Close:

$46.38

Open:

$46.85

24h Volume:

317.15K

Relative Volume:

0.80

Market Cap:

$1.03B

Revenue:

$1.77M

Net Income/Loss:

$-123.74M

P/E Ratio:

-5.3195

EPS:

-9.17

Net Cash Flow:

$-95.21M

1W Performance:

+3.61%

1M Performance:

-11.97%

6M Performance:

-34.51%

1Y Performance:

-1.97%

1-Day Range:

$46.01

$49.10

1-Week Range:

$44.15

$49.10

52-Week Range:

$26.70

$91.83

Praxis Precision Medicines Inc Stock (PRAX) Company Profile

Name

Praxis Precision Medicines Inc

Sector

Healthcare (1157)

Industry

Biotechnology (645)

Phone

617-300-8460

Address

99 HIGH STREET, 30TH FLOOR, BOSTON

Employee

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

PRAX's Discussions on Twitter

Compare PRAX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
PRAX Praxis Precision Medicines Inc	48.78	981.36M	1.77M	-123.74M	-95.21M	-9.17
VRTX Vertex Pharmaceuticals Inc	395.12	99.96B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	589.48	60.83B	14.21B	4.46B	3.56B	39.68
ALNY Alnylam Pharmaceuticals Inc	454.38	59.89B	2.46B	-319.09M	-52.09M	-2.47
ARGX Argen X Se Adr	660.00	40.47B	3.06B	1.28B	447.35M	21.30
ONC Beone Medicines Ltd Adr	313.67	37.96B	3.81B	-644.79M	-669.77M	-6.24

Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jun-02-25	Resumed	Oppenheimer	Outperform
May-07-25	Initiated	Chardan Capital Markets	Buy
Mar-03-25	Reiterated	H.C. Wainwright	Buy
Feb-11-25	Initiated	Deutsche Bank	Buy
Aug-05-24	Initiated	Oppenheimer	Outperform
Jun-24-24	Initiated	Needham	Buy
Jun-18-24	Initiated	Guggenheim	Buy
May-01-24	Initiated	Robert W. Baird	Outperform
Sep-19-23	Initiated	Truist	Buy
Jun-06-22	Downgrade	Wedbush	Outperform → Neutral
Dec-16-21	Initiated	H.C. Wainwright	Buy
Aug-26-21	Initiated	BofA Securities	Buy
Apr-26-21	Initiated	William Blair	Outperform
Nov-11-20	Initiated	Wedbush	Outperform
Nov-10-20	Initiated	Cowen	Outperform
Nov-10-20	Initiated	Evercore ISI	Outperform
Nov-10-20	Initiated	Piper Sandler	Overweight

View All

Praxis Precision Medicines Inc Stock (PRAX) Latest News

Aug 20, 2025

Can Praxis Precision Medicines Inc. rally from current levelsWeekly Profit Analysis & Technical Pattern Recognition Alerts - Newser

Aug 20, 2025

Evaluating Praxis Precision Medicines Inc. with trendline analysisJuly 2025 Snapshot & Fast Moving Stock Watchlists - Newser

Aug 20, 2025

Using AI based signals to follow Praxis Precision Medicines Inc.July 2025 Reactions & Weekly Hot Stock Watchlists - Newser

Aug 20, 2025

Tools to monitor Praxis Precision Medicines Inc. recovery probabilityQuarterly Trade Review & Consistent Income Trade Ideas - Newser

Aug 20, 2025

Measuring Praxis Precision Medicines Inc.’s beta against major indicesEarnings Overview Summary & Momentum Based Trading Signals - Newser

Aug 20, 2025

Analyzing Praxis Precision Medicines Inc. with risk reward ratio chartsJuly 2025 Momentum & Free Expert Approved Momentum Trade Ideas - Newser

Aug 20, 2025

Praxis Precision Medicines Inc. stock momentum explainedQuarterly Investment Review & Safe Entry Trade Reports - Newser

Aug 20, 2025

Order flow analysis tools used on Praxis Precision Medicines Inc.Portfolio Value Report & Technical Confirmation Trade Alerts - Newser

Aug 20, 2025

Advanced analytics toolkit walkthrough for Praxis Precision Medicines Inc.Weekly Earnings Recap & AI Powered Buy/Sell Recommendations - Newser

Aug 20, 2025

Aug 19, 2025

Praxis Precision Medicines Inc. stock retracement – recovery analysisJuly 2025 Update & Fast Gain Stock Trading Tips - Newser

Aug 19, 2025

Is Praxis Precision Medicines Inc. reversing from oversold territory2025 Year in Review & Expert Verified Movement Alerts - Newser

Aug 19, 2025

Momentum Screeners Rank Praxis Precision Medicines Inc. in Top 5 TodayJuly 2025 News Drivers & Detailed Earnings Play Alerts - beatles.ru

Aug 19, 2025

How sentiment analysis helps forecast Praxis Precision Medicines Inc.2025 Momentum Check & Weekly Sector Rotation Insights - Newser

Aug 19, 2025

Top chart patterns to watch in Praxis Precision Medicines Inc.2025 Earnings Surprises & Technical Pattern Recognition Alerts - Newser

Aug 19, 2025

Comparing Praxis Precision Medicines Inc. in custom built stock radarsWeekly Risk Summary & Precise Buy Zone Tips - Newser

Aug 19, 2025

Published on: 2025-08-19 14:32:25 - Newser

Aug 19, 2025

Praxis Precision Medicines Inc. Uptrend in Early Stages Indicators Say YesMarket Risk Analysis & Free Technical Confirmation Trade Alerts - beatles.ru

Aug 19, 2025

Aug 18, 2025

Lost Money on Praxis Precision Medicines, Inc. (PRAX)? Possible FraudContact Levi & Korsinsky Today - ACCESS Newswire

Aug 18, 2025